Corrigendum to "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan" [Lung Cancer, 129 (March) (2019) 55-62]

Lung Cancer. 2019 Jun:132:157-158. doi: 10.1016/j.lungcan.2019.04.010. Epub 2019 Apr 20.
No abstract available

Publication types

  • Published Erratum